Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma

Early diagnosis and treatment in pancreatic ductal adenocarcinoma (PDAC) is still a challenge worldwide. The poor survival of PDAC patients mainly due to early metastasis when first diagnosed and lack of prognostic biomarker. Ribosomal protein L15 (RPL15), an RNA-binding protein, is a component of r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yan, Ting-Ting, Fu, Xue-Liang, Li, Jiao, Bian, Ying-Nan, Liu, De-Jun, Hua, Rong, Ren, Lin-Lin, Li, Cheng-Tao, Sun, Yong-Wei, Chen, Hao-Yan, Fang, Jing-Yuan, Hong, Jie
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper: Pathology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741913/
https://ncbi.nlm.nih.gov/pubmed/26498693
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars